Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Clinical Pharmacy
CP-003
CLINICAL PHARMACIST INTERVENTIONS ON PARENTERAL NUTRITION APPROPRIATENESS IN A TEACHING HOSPITAL
CP-002
PHARMACEUTICAL CARE SYSTEM FOR LIVER TRANSPLANT PATIENTS USING ELECTRONIC CONSULTATION
CP-001
IMPACT OF A PHARMACEUTICAL CARE PROGRAMME FOCUSED ON THE SOLID ORGAN TRANSPLANT PATIENT
CP-087
EVALUATION OF THE SAFETY AND EFFICACY OF MITOXANTRONE IN CYPRIOT PATIENTS WITH WORSENING FORMS OF MULTIPLE SCLEROSIS
CP-153
COMPARISON OF 5 HEALTH CARE PROFESSIONALS’RATINGS OF THE CLINICAL SIGNIFICANCE OF DRUG RELATED PROBLEMS
CP-045
ADEQUACY OF INTRAVENOUS IMMUNOGLOBULIN PRESCRIPTION AT A TEACHING HOSPITAL
CP-099
ECONOMIC IMPACT OF OPTIMISING BIOLOGIC THERAPIES FOR ARTHROPATHIES
CP-088
SURVIVAL TIME OF BIOLOGICAL TREATMENTS IN PSORIASIS
CP-095
IS THE EMERGENCY PHARMACIST ROLE ACCEPTED BY EMERGENCY DEPARTMENT STAFF?
CP-092
CLINICAL AUDIT OF PRESCRIPTIONS OF PROTHROMBIN COMPLEX CONCENTRATE IN A SMALL HOSPITAL
CP-066
INTERLEUKIN-28B POLYMOPHISM AS A PREDICTOR OF RESPONSE TO TELAPREVIR-BASED REGIMENS IN PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION
CP-065
EFFECTIVENESS IN GENOTYPES 1B, 1A IN PATIENTS WITH HEPATITIS C VIRUS INFECTION TREATED WITH TELAPREVIR-BASED TREATMENT
CP-155
MISSED AND DELAYED DOSES OF PARKINSON’S MEDICINES AT NORTH BRISTOL NHS TRUST (NBT) (UK)
CP-150
IMPLEMENTATION OF AN INTEGRATED MULTIFACETED APPROACH TO IMPROVE CRUSHING PRACTICE ON HOSPITAL WARDS
CP-148
COMPARATIVE EFFICACY AND SAFETY OF TUMOUR NECROSIS FACTOR ALPHA BLOCKERS (ANTI-TNF) IN NON-FISTULIZING CROHN’S DISEASE
Pages
« first
‹ previous
…
24
25
26
27
28
29
30
31
32
next ›
last »
Follow Us